Compare TNON & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNON | BFRG |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8M | 9.2M |
| IPO Year | 2022 | 2023 |
| Metric | TNON | BFRG |
|---|---|---|
| Price | $0.67 | $0.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 91.1K | ★ 362.6K |
| Earning Date | 03-19-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,233,000.00 | $116,670.00 |
| Revenue This Year | $19.56 | N/A |
| Revenue Next Year | $71.06 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.67 | $0.50 |
| 52 Week High | $5.85 | $4.84 |
| Indicator | TNON | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 19.23 | 27.48 |
| Support Level | $0.67 | $0.70 |
| Resistance Level | $0.97 | $0.82 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 3.33 | 2.00 |
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.